Adverse Drug Reaction Classification System
Drug ID |
Drug Name
|
CAS RN
|
Molecular Formula
|
Structure
|
BADD_D00061 | Alcohol | 64-17-5 | C2H6O | |
BADD_D00062 | Aldesleukin | 110942-02-4 | Not Available | |
BADD_D00063 | Alectinib hydrochloride | 1256589-74-8 | C30H35ClN4O2 | |
BADD_D00064 | Alemtuzumab | 216503-57-0 | Not Available | |
BADD_D00065 | Alendronate sodium | 129318-43-0 | C4H13NNaO7P2 | |
BADD_D00066 | Alendronic acid | 66376-36-1 | C4H13NO7P2 | |
BADD_D00067 | Alfentanil | 71195-58-9 | C21H32N6O3 | |
BADD_D00068 | Alfentanil hydrochloride | 69049-06-5 | C21H33ClN6O3 | |
BADD_D00069 | Alfuzosin | 81403-80-7 | C19H27N5O4 | |
BADD_D00070 | Alfuzosin hydrochloride | 81403-68-1 | C19H28ClN5O4 | |
BADD_D00071 | Alglucosidase alfa | 420784-05-0 | Not Available | |
BADD_D00072 | Alirocumab | 1245916-14-6 | Not Available | |
BADD_D00073 | Aliskiren | 173334-57-1 | C30H53N3O6 | |
BADD_D00074 | Aliskiren hemifumarate | 173334-58-2 | C64H110N6O16 | |
BADD_D00075 | Alitretinoin | 5300-03-8 | C20H28O2 | |
BADD_D00076 | Allopurinol | 315-30-0 | C5H4N4O | |
BADD_D00077 | Almotriptan | 154323-57-6 | C17H25N3O2S | |
BADD_D00078 | Almotriptan malate | 181183-52-8 | C21H31N3O7S | |
BADD_D00079 | Alogliptin | 850649-61-5 | C18H21N5O2 | |
BADD_D00080 | Alogliptin benzoate | 850649-62-6 | C25H27N5O4 | |
BADD_D00081 | Alomide | 63610-09-3 | C15H17ClN4O9 | |
BADD_D00082 | Alosetron | 122852-42-0 | C17H18N4O | |
BADD_D00083 | Alosetron hydrochloride | 122852-69-1 | C17H19ClN4O | |
BADD_D00084 | Alpha-1-proteinase inhibitor (human) | 9041-92-3 | Not Available | |
BADD_D00085 | Alprazolam | 28981-97-7 | C17H13ClN4 | |
BADD_D00086 | Alprostadil | 745-65-3 | C20H34O5 | |
BADD_D00087 | Alteplase | 177799-16-5 | C42H36N2 | |
BADD_D00088 | Altretamine | 645-05-6 | C9H18N6 | |
BADD_D00089 | Aluminum chloride hexahydrate | 7784-13-6 | AlCl3H12O6 | |
BADD_D00090 | Aluminum chlorohydrate | 12359-72-7 | Not Available | |